113 related articles for article (PubMed ID: 9265994)
1. Monitoring of disease activity by measurement of inflammatory markers in atopic dermatitis in childhood.
Halmerbauer G; Frischer T; Koller DY
Allergy; 1997 Jul; 52(7):765-9. PubMed ID: 9265994
[TBL] [Abstract][Full Text] [Related]
2. Changes of serum levels of interleukin-2, intercellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1 and Th1 and Th2 cell in severe atopic dermatitis after intravenous immunoglobulin therapy.
Huang JL; Lee WY; Chen LC; Kuo ML; Hsieh KH
Ann Allergy Asthma Immunol; 2000 Mar; 84(3):345-52. PubMed ID: 10752921
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of serologic immune parameters in inflammatory skin diseases.
Gebhardt M; Wenzel HC; Hipler UC; Herrmann D; Wollina U
Allergy; 1997 Nov; 52(11):1087-94. PubMed ID: 9404560
[TBL] [Abstract][Full Text] [Related]
4. Serum soluble IL-2 receptor (sIL-2R) and eosinophil cationic protein (ECP) levels in atopic dermatitis.
Furue M; Sugiyama H; Tsukamoto K; Ohtake N; Tamaki K
J Dermatol Sci; 1994 Apr; 7(2):89-95. PubMed ID: 8060919
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma.
Stelmach I; Jerzynska J; Kuna P
J Allergy Clin Immunol; 2002 Feb; 109(2):257-63. PubMed ID: 11842294
[TBL] [Abstract][Full Text] [Related]
6. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis.
Czech W; Krutmann J; Schöpf E; Kapp A
Br J Dermatol; 1992 Apr; 126(4):351-5. PubMed ID: 1571256
[TBL] [Abstract][Full Text] [Related]
7. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis.
Kägi MK; Joller-Jemelka H; Wüthrich B
Dermatology; 1992; 185(2):88-92. PubMed ID: 1421636
[TBL] [Abstract][Full Text] [Related]
8. Markers of allergic inflammation in peripheral blood of children with asthma after treatment with inhaled triamcinolone acetonide.
Stelmach I; Jerzynska J; Kuna P
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):319-26. PubMed ID: 11686425
[TBL] [Abstract][Full Text] [Related]
9. Relationship between disease severity and inflammatory markers in cystic fibrosis.
Koller DY; Götz M; Wojnarowski C; Eichler I
Arch Dis Child; 1996 Dec; 75(6):498-501. PubMed ID: 9014602
[TBL] [Abstract][Full Text] [Related]
10. Measurement of inflammatory mediators of eosinophils and lymphocytes in blood in acute asthma: serum levels of ECP influence the bronchodilator response.
Di Lorenzo G; Pacor ML; Morici G; Drago A; Esposito-Pellitteri M; Candore G; Lo Bianco C; Caruso C
Int Arch Allergy Immunol; 2002 Apr; 127(4):308-15. PubMed ID: 12021550
[TBL] [Abstract][Full Text] [Related]
11. Soluble E-selectin, other markers of inflammation and disease severity in children with atopic dermatitis.
Wolkerstorfer A; Laan MP; Savelkoul HF; Neijens HJ; Mulder PG; Oudesluys-Murphy AM; Sukhai RN; Oranje AP
Br J Dermatol; 1998 Mar; 138(3):431-5. PubMed ID: 9580795
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis.
Wüthrich B; Kägi MK; Joller-Jemelka H
Arch Dermatol Res; 1992; 284(6):339-42. PubMed ID: 1284103
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind trial of the effect of treatment with formoterol on clinical and inflammatory parameters of asthma in children.
Stelmach I; Gorski P; Jerzynska J; Stelmach W; Majak P; Kuna P
Ann Allergy Asthma Immunol; 2002 Jul; 89(1):67-73. PubMed ID: 12141723
[TBL] [Abstract][Full Text] [Related]
14. Circulating ICAM-1 levels in children with atopic dermatitis.
Kojima T; Ono A; Aoki T; Kameda-Hayashi N; Kobayashi Y
Ann Allergy; 1994 Oct; 73(4):351-5. PubMed ID: 7944004
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, randomized, placebo-controlled trial of effect of nedocromil sodium on clinical and inflammatory parameters of asthma in children allergic to dust mite.
Stelmach I; Jerzynska J; Brzozowska A; Kuna P
Allergy; 2001 Jun; 56(6):518-24. PubMed ID: 11421896
[TBL] [Abstract][Full Text] [Related]
16. [Peripheral eosinophil counts relates the improvement of the skin lesions of atopic dermatitis patients more sensitive than serum eosinophil cationic protein levels].
Nishimoto M; Numahara T; Nakashima K; Yoshida T
Arerugi; 1998 Jun; 47(6):591-6. PubMed ID: 9721450
[TBL] [Abstract][Full Text] [Related]
17. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
Angelova-Fischer I; Hipler UC; Bauer A; Fluhr JW; Tsankov N; Fischer TW; Elsner P
Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil involvement in atopic dermatitis as reflected by elevated serum levels of eosinophil cationic protein.
Tsuda S; Kato K; Miyasato M; Sasai Y
J Dermatol; 1992 Apr; 19(4):208-13. PubMed ID: 1607481
[TBL] [Abstract][Full Text] [Related]
19. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.
Schmitt WH; Csernok E; Kobayashi S; Klinkenborg A; Reinhold-Keller E; Gross WL
Arthritis Rheum; 1998 Mar; 41(3):445-52. PubMed ID: 9506572
[TBL] [Abstract][Full Text] [Related]
20. Serum eosinophil cationic protein in patients with atopic dermatitis.
Paganelli R; Fanales-Belasio E; Carmini D; Scala E; Meglio P; Businco L; Aiuti F
Int Arch Allergy Appl Immunol; 1991; 96(2):175-8. PubMed ID: 1769747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
